BACKGROUND: Left ventricular (LV) global longitudinal strain (GLS) is a measure of the active shortening of the LV in the longitudinal direction, which can be assessed with speckle-tracking echocardiography. The aims of this evaluation were to validate the prognostic value of GLS as a new index of LV systolic function in a large cohort of patients with chronic ischemic cardiomyopathy and to determine the incremental value of GLS to predict long-term outcome over other strong and well-established prognostic factors. METHODS AND RESULTS: A total of 1060 patients underwent baseline clinical evaluation and transthoracic echocardiography. Median age was 66.9 years (interquartile range, 58.4, 74.2 years); 739 (70%) were men. The median follow-up duration for the entire patient population was 31 months. During the follow-up, 270 patients died and 309 patients reached the combined end point (all-cause mortality and heart failure hospitalization). Compared with survivors, patients who died (270, [25%]) had larger LV volumes (P<0.05), lower LV ejection fraction (P=0.004), higher wall motion score index (P=0.001), and greater impairment of LV GLS (P<0.001). After dichotomizing the population on the basis of the median value of LV GLS (-11.5%), patients with an LV GLS ≤-11.5% had superior outcome compared with patients with an LV GLS >-11.5% (log-rank χ(2), 13.86 and 14.16 for all-cause mortality and combined end point, respectively, P<0.001 for both). On multivariate analysis, GLS was independently related to all-cause mortality (hazard ratio per 5% increase, 1.69; 95% confidence interval, 1.33-2.15; P<0.001) and combined end point (1.64; 95% confidence interval, 1.32-2.04; P<0.001). CONCLUSIONS: The assessment of LV GLS with speckle-tracking echocardiography is significantly related to long-term outcome in patients with chronic ischemic cardiomyopathy.
BACKGROUND: Left ventricular (LV) global longitudinal strain (GLS) is a measure of the active shortening of the LV in the longitudinal direction, which can be assessed with speckle-tracking echocardiography. The aims of this evaluation were to validate the prognostic value of GLS as a new index of LV systolic function in a large cohort of patients with chronic ischemic cardiomyopathy and to determine the incremental value of GLS to predict long-term outcome over other strong and well-established prognostic factors. METHODS AND RESULTS: A total of 1060 patients underwent baseline clinical evaluation and transthoracic echocardiography. Median age was 66.9 years (interquartile range, 58.4, 74.2 years); 739 (70%) were men. The median follow-up duration for the entire patient population was 31 months. During the follow-up, 270 patients died and 309 patients reached the combined end point (all-cause mortality and heart failure hospitalization). Compared with survivors, patients who died (270, [25%]) had larger LV volumes (P<0.05), lower LV ejection fraction (P=0.004), higher wall motion score index (P=0.001), and greater impairment of LV GLS (P<0.001). After dichotomizing the population on the basis of the median value of LV GLS (-11.5%), patients with an LV GLS ≤-11.5% had superior outcome compared with patients with an LV GLS >-11.5% (log-rank χ(2), 13.86 and 14.16 for all-cause mortality and combined end point, respectively, P<0.001 for both). On multivariate analysis, GLS was independently related to all-cause mortality (hazard ratio per 5% increase, 1.69; 95% confidence interval, 1.33-2.15; P<0.001) and combined end point (1.64; 95% confidence interval, 1.32-2.04; P<0.001). CONCLUSIONS: The assessment of LV GLS with speckle-tracking echocardiography is significantly related to long-term outcome in patients with chronic ischemic cardiomyopathy.
Authors: Michael J Bonios; Antigone Koliopoulou; Omar Wever-Pinzon; Iosif Taleb; Josef Stehlik; Weining Xu; James Wever-Pinzon; Anna Catino; Abdallah G Kfoury; Benjamin D Horne; Jose Nativi-Nicolau; Stamatis N Adamopoulos; James C Fang; Craig H Selzman; Jeroen J Bax; Stavros G Drakos Journal: Circ Cardiovasc Imaging Date: 2018-04 Impact factor: 7.792
Authors: Martina Chantal de Knegt; A Fuchs; P Weeke; R Møgelvang; C Hassager; K F Kofoed Journal: Int J Cardiovasc Imaging Date: 2016-08-18 Impact factor: 2.357
Authors: Madalena Coutinho Cruz; Ana Abreu; Guilherme Portugal; Helena Santa-Clara; Pedro S Cunha; Mario M Oliveira; Vanessa Santos; Luís Oliveira; Pedro Rio; Inês Rodrigues; Luís A Morais; Rui C Ferreira; Miguel M Carmo Journal: J Nucl Cardiol Date: 2017-12-05 Impact factor: 5.952
Authors: Andrea Sonaglioni; Gian Luigi Nicolosi; Michele Lombardo; Gian Franco Gensini; Giuseppe Ambrosio Journal: Int J Cardiovasc Imaging Date: 2020-10-30 Impact factor: 2.357
Authors: Richard J Boruta; Shelley D Miyamoto; Adel K Younoszai; Sonali S Patel; Bruce F Landeck Journal: Pediatr Cardiol Date: 2017-09-25 Impact factor: 1.655